tetano
Editor, Senior Moderator
Intern Med
. 2022 Oct 5.
doi: 10.2169/internalmedicine.0190-22. Online ahead of print.
Timeline of Oxygen Demand in Patients with COVID-19 Pneumonia
Tsuneyuki Oda[SUP] 1 [/SUP], Eri Hagiwara[SUP] 1 [/SUP], Takafumi Yamaya[SUP] 1 [/SUP], Takashi Ogura[SUP] 1 [/SUP]
Affiliations
Abstract
Objective In patients with coronavirus disease 2019 (COVID-19), understanding the timeline of oxygen demand and severe respiratory failure, such as intensive-care unit (ICU) admission, may clarify the therapeutic window when home-care treatment is possible and help determine the timing of treatment in hospitalized patients to improve the respiratory status. We examined the timeline of respiratory status in hospitalized patients with moderate-to-severe COVID-19 in terms of oxygen demand and ICU admission. Methods We retrospectively assessed all patients with COVID-19 who were admitted to our hospital between February 2020 and February 2021 and required supplemental oxygen. This study included 66 patients who were transferred to the ICU (ICU patients) and 144 patients who were not transferred to the ICU (non-ICU patients). Results In the total cohort, the median duration from symptom onset to the need for supplemental oxygen was 8 (interquartile range [IQR] 6-10) days. This duration was significantly shorter in ICU patients than in non-ICU patients [8 (IQR 6-9) vs. 9 (IQR 6-10) days, p = 0.02]. The median duration from symptom onset to ICU admission was 9 (IQR 8-11) days in severely ill patients. The median duration from the initiation of supplemental oxygen to ICU admission was 1.0 (IQR 1-2.75) days. Only 2 of 66 patients (3.0%) were admitted to the ICU six days or later after initiation of supplemental oxygen. Conclusions Physicians should carefully monitor each patient's condition after eight days from symptom onset. New therapies and their early administration are needed to reduce the frequency of respiratory failure in COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; corticosteroid; organizing pneumonia; oxygen; timeline
. 2022 Oct 5.
doi: 10.2169/internalmedicine.0190-22. Online ahead of print.
Timeline of Oxygen Demand in Patients with COVID-19 Pneumonia
Tsuneyuki Oda[SUP] 1 [/SUP], Eri Hagiwara[SUP] 1 [/SUP], Takafumi Yamaya[SUP] 1 [/SUP], Takashi Ogura[SUP] 1 [/SUP]
Affiliations
- PMID: 36198590
- DOI: 10.2169/internalmedicine.0190-22
Abstract
Objective In patients with coronavirus disease 2019 (COVID-19), understanding the timeline of oxygen demand and severe respiratory failure, such as intensive-care unit (ICU) admission, may clarify the therapeutic window when home-care treatment is possible and help determine the timing of treatment in hospitalized patients to improve the respiratory status. We examined the timeline of respiratory status in hospitalized patients with moderate-to-severe COVID-19 in terms of oxygen demand and ICU admission. Methods We retrospectively assessed all patients with COVID-19 who were admitted to our hospital between February 2020 and February 2021 and required supplemental oxygen. This study included 66 patients who were transferred to the ICU (ICU patients) and 144 patients who were not transferred to the ICU (non-ICU patients). Results In the total cohort, the median duration from symptom onset to the need for supplemental oxygen was 8 (interquartile range [IQR] 6-10) days. This duration was significantly shorter in ICU patients than in non-ICU patients [8 (IQR 6-9) vs. 9 (IQR 6-10) days, p = 0.02]. The median duration from symptom onset to ICU admission was 9 (IQR 8-11) days in severely ill patients. The median duration from the initiation of supplemental oxygen to ICU admission was 1.0 (IQR 1-2.75) days. Only 2 of 66 patients (3.0%) were admitted to the ICU six days or later after initiation of supplemental oxygen. Conclusions Physicians should carefully monitor each patient's condition after eight days from symptom onset. New therapies and their early administration are needed to reduce the frequency of respiratory failure in COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; corticosteroid; organizing pneumonia; oxygen; timeline